UOC
IQMD

UBS O'Connor’s Intelligent Medicine Acquisition Corp. Class A Common Stock IQMD Stock Holding History

UBS O'Connor’s Portfolio IQMD Stock Details IQMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-378,097
Closed -$3.89M – 789
2022
Q4 		$3.89M Sell
378,097
-3,700
-1% -$37.6K 0.07% 253
2022
Q3 		$3.85M Sell
381,797
-38,221
-9% -$384K 0.04% 368
2022
Q2 		$4.21M Hold
420,018
– – 0.04% 370
2022
Q1 		$4.2M Buy
+420,018
New +$4.17M 0.05% 332

Other funds holding IQMD

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
CF
Cantor Fitzgerald New York $9.31B AUM 73.66% 1-Year Est. Return
Walleye Trading
Walleye Trading New York $87.6B AUM 68.17% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
AF
Allworth Financial Folsom, California $23.6B AUM 20.99% 1-Year Est. Return

UBS O'Connor's IQMD Position: Q1 2023 in Review

UBS O'Connor sold out of Intelligent Medicine Acquisition Corp. Class A Common Stock (IQMD) in Q1 2023, closing a stake of 378,097 shares — an estimated $3.89M sold.

UBS O'Connor first reported a position in IQMD in Q1 2022 and held it in 4 quarters. The position peaked at $4.21M in Q2 2022. 8 funds tracked by Wall St. Rank hold IQMD as of Q1 2023.

  • UBS O'Connor reported no remaining Intelligent Medicine Acquisition Corp. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
  • UBS O'Connor sold 378,097 Intelligent Medicine Acquisition Corp. Class A Common Stock shares in Q1 2023, an estimated $3.89M.
  • UBS O'Connor first reported a position in Intelligent Medicine Acquisition Corp. Class A Common Stock in Q1 2022 and held it in 4 quarters.
  • UBS O'Connor's Intelligent Medicine Acquisition Corp. Class A Common Stock position peaked at $4.21M in Q2 2022.
  • 8 funds tracked by Wall St. Rank held Intelligent Medicine Acquisition Corp. Class A Common Stock as of Q1 2023.

Based on UBS O'Connor's 13F filing for Q1 2023, filed 15 May 2023.